KornnacCaps has successfully completed the shipment of a batch of high-quality Size 1 HPMC (Hypromellose) capsules to a client in Hungary. This export marks a solid step forward for KornnacCaps, in expanding into the high-end European plant-based capsule market. It further validates the international market's recognition of high-quality Made in China pharmaceutical excipients.
HPMC capsules, commonly known as "vegetarian capsules" or "plant-based capsules," are derived from plant cellulose. They not only contain no animal ingredients but also offer significant advantages such as low moisture content, chemical stability, and no risk of cross-linking reactions. These properties make them particularly suitable for filling hygroscopic or oily content. In recent years, driven by the surge in global consumer demand for Clean Label and vegetarian health products, the demand for plant-based capsules in the European market has maintained high growth. The Size 1 HPMC capsules shipped this time represent an ideal specification customized based on the client's need to fill specific health supplement formulas, balancing both loading capacity and patient convenience.
To ensure the product remained undamaged during the long-distance transnational transport, KornnacCaps strictly implemented the "Guidelines for Capsule Storage and Transportation" recently released by the company. Addressing the sensitivity of both gelatin capsules and vegetable capsules to temperature and humidity, and considering that the shipment coincides with the changing of seasons, the company conducted strict pre-conditioning of the shipping container before dispatch to ensure temperature equilibrium. Comprehensive measures were taken regarding moisture protection, light avoidance, and shock resistance. All finished products were placed on hard pallets to avoid compression deformation during transit, demonstrating a commitment to delivering the perfect product to the client's hands.
A relevant person in charge of KornnacCaps stated: "Hungary is an important pharmaceutical hub in Central and Eastern Europe. This successful cooperation with the Hungarian client is a crucial part of our strategy to deeply cultivate the European market. KornnacCaps always adheres to driving quality upgrades through technological innovation. Our HPMC capsule production line has achieved a high level of automation and intelligence, ensuring that every capsule meets international pharmacopoeia standards. We look forward to establishing a long-term and stable strategic partnership with our Hungarian client through this shipment."
Looking ahead, KornnacCaps will continue to dedicate itself to the R&D and production of more innovative products, responding to the higher requirements of the global pharmaceutical industry for safety, environmental protection, and health, and providing superior capsule solutions for clients worldwide.
